12:00 AM
Nov 17, 2008
 |  BC Week In Review  |  Company News  |  Deals

Antyra, Novo Nordisk deal

Antyra (formerly DGI Biotechnologies Inc.) received exclusive, worldwide rights from Novo Nordisk to develop and commercialize insulin-like growth factor (IGF)...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >